cysteamine has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, X; Li, W; Ling, S; Liu, X; Luo, Y; Wang, A; Xu, B; Yao, X; Zhang, S; Zhou, Y; Zong, W | 1 |
| Bergers, M; de Jongh, GJ; Jansen, PA; Kamsteeg, M; Rodijk-Olthuis, D; Schalkwijk, J; Tjabringa, GS; van Vlijmen-Willems, IM; Zeeuwen, PL | 1 |
2 other study(ies) available for cysteamine and Psoriasis
| Article | Year |
|---|---|
Transglutaminase 3 Attenuates Skin Inflammation in Psoriasis by Inhibiting NF-κB Activation through Phosphorylated STAT3-TET3 Signaling.
Topics: Animals; Cysteamine; Cytokines; Dermatitis; Disease Models, Animal; Imiquimod; Inflammation; Keratinocytes; Mice; Mice, Inbred BALB C; NF-kappa B; Psoriasis; RNA, Small Interfering; Skin; STAT3 Transcription Factor; Transglutaminases | 2022 |
Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines.
Topics: Amidohydrolases; Caspase Inhibitors; Cell Adhesion Molecules; Cysteamine; Cytokines; Gene Expression Regulation; GPI-Linked Proteins; Humans; Hydrolases; Keratinocytes; PPAR gamma; Psoriasis; RNA, Messenger; Skin; Transglutaminases | 2009 |